{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T13:49:52Z","timestamp":1789566592764,"version":"build-2803163510"},"reference-count":128,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.ejmech.2021.113539","type":"journal-article","created":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T11:35:10Z","timestamp":1620992110000},"page":"113539","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Inhibitors of BCL2A1\/Bfl-1 protein: Potential stock in cancer therapy"],"prefix":"10.1016","volume":"220","author":[{"given":"Xue","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junwei","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qidong","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengyu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2021.113539_bib1","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0092-8674(04)00046-7","article-title":"Cell death: critical control points","volume":"116","author":"Danial","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2021.113539_bib2","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.cell.2011.10.033","article-title":"Programmed cell death in animal development and disease","volume":"147","author":"Fuchs","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2021.113539_bib3","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/01926230701320337","article-title":"Apoptosis: a review of programmed cell death","volume":"35","author":"Elmore","year":"2007","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.ejmech.2021.113539_bib4","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1056\/NEJMra0901217","article-title":"Cell death","volume":"361","author":"Hotchkiss","year":"2009","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2021.113539_bib5","doi-asserted-by":"crossref","first-page":"106913","DOI":"10.1016\/j.intimp.2020.106913","article-title":"The assessment of a possible link between HPV-mediated inflammation, apoptosis, and angiogenesis in Prostate cancer","volume":"88","author":"Sadri Nahand","year":"2020","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.ejmech.2021.113539_bib6","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1146\/annurev.biochem.69.1.217","article-title":"Apoptosis signaling","volume":"69","author":"Strasser","year":"2000","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ejmech.2021.113539_bib7","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.immuni.2013.06.014","article-title":"Mechanism of action of conventional and targeted anticancer therapies: reinstating immunosurveillance","volume":"39","author":"Zitvogel","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.ejmech.2021.113539_bib8","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s11523-012-0212-2","article-title":"A\u00a0review on various targeted anticancer therapies","volume":"7","author":"Li","year":"2012","journal-title":"Targeted Oncol."},{"key":"10.1016\/j.ejmech.2021.113539_bib9","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1046\/j.1365-2184.2003.00267.x","article-title":"Cell cycle and apoptosis","volume":"36","author":"Vermeulen","year":"2003","journal-title":"Cell Prolif"},{"key":"10.1016\/j.ejmech.2021.113539_bib10","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ejmech.2019.05.067","article-title":"Anti-cancer effects of cinnamon: insights into its apoptosis effects","volume":"178","author":"Sadeghi","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113539_bib11","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nrd.2016.253","article-title":"From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors","volume":"16","author":"Ashkenazi","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2021.113539_bib12","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1136\/jmg.2009.066944","article-title":"Apoptosis and cancer: mutations within caspase genes","volume":"46","author":"Ghavami","year":"2009","journal-title":"J.\u00a0Med. Genet."},{"key":"10.1016\/j.ejmech.2021.113539_bib13","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1038\/sj.leu.2403112","article-title":"Synthetic triterpenoids activate a pathway for apoptosis in AML cells involving downregulation of FLIP and sensitization to TRAIL","volume":"17","author":"Suh","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.ejmech.2021.113539_bib14","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/cdd.2012.92","article-title":"Prophylactic treatment with the BH3 mimetic ABT-737 impedes Myc-driven lymphomagenesis in mice","volume":"20","author":"Kelly","year":"2013","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ejmech.2021.113539_bib15","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1007\/s12031-020-01639-z","article-title":"Combination therapy with nanomicellar-curcumin and temozolomide for in\u00a0vitro therapy of glioblastoma multiforme via wnt signaling pathways","volume":"70","author":"Bagherian","year":"2020","journal-title":"J.\u00a0Mol. Neurosci."},{"key":"10.1016\/j.ejmech.2021.113539_bib16","doi-asserted-by":"crossref","first-page":"153082","DOI":"10.1016\/j.prp.2020.153082","article-title":"Nanomicellar-curcumin exerts its therapeutic effects via affecting angiogenesis, apoptosis, and T cells in a mouse model of melanoma lung metastasis","volume":"216","author":"Mardani","year":"2020","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.ejmech.2021.113539_bib17","doi-asserted-by":"crossref","first-page":"1212369","DOI":"10.1155\/2019\/1212369","article-title":"Drugs and clinical approaches targeting the antiapoptotic protein: a review","volume":"2019","author":"Han","year":"2019","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.ejmech.2021.113539_bib18","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/cdd.2017.161","article-title":"The BCL-2 arbiters of apoptosis and their growing role as cancer targets","volume":"25","author":"Adams","year":"2017","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ejmech.2021.113539_bib19","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.bbamcr.2003.08.012","article-title":"Structural biology of the Bcl-2 family of proteins","volume":"1644","author":"Andrew","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejmech.2021.113539_bib20","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.molcel.2010.01.025","article-title":"The BCL-2 family reunion","volume":"37","author":"Chipuk","year":"2010","journal-title":"Mol. Cell."},{"key":"10.1016\/j.ejmech.2021.113539_bib21","doi-asserted-by":"crossref","first-page":"8590","DOI":"10.1038\/sj.onc.1207102","article-title":"The Bcl-2 family: roles in cell survival and oncogenesis","volume":"22","author":"Cory","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.ejmech.2021.113539_bib22","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.tcb.2008.01.007","article-title":"How do BCL-2 proteins induce mitochondrial outer membrane permeabilization?","volume":"18","author":"C","year":"2008","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.ejmech.2021.113539_bib23","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.yexcr.2012.01.021","article-title":"A1\/Bfl-1 in leukocyte development and cell death","volume":"318","author":"Ottina","year":"2012","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.ejmech.2021.113539_bib24","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1038\/cdd.2011.17","article-title":"The role of Bcl-2 and its pro-survival relatives in tumourigenesis and cancer therapy","volume":"18","author":"Kelly","year":"2011","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ejmech.2021.113539_bib25","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.molcel.2011.10.001","article-title":"A\u00a0unified model of mammalian BCL-2 protein family interactions at the mitochondria","volume":"44","author":"Llambi","year":"2011","journal-title":"Mol. Cell."},{"key":"10.1016\/j.ejmech.2021.113539_bib26","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nm.3048","article-title":"ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets","volume":"19","author":"Souers","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejmech.2021.113539_bib27","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.1158\/0008-5472.CAN-07-5836","article-title":"ABT-263: a potent and orally bioavailable Bcl-2 family inhibitor","volume":"68","author":"Tse","year":"2008","journal-title":"Canc. Res"},{"key":"10.1016\/j.ejmech.2021.113539_bib28","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1021\/jm0507532","article-title":"Discovery of a potent inhibitor of the antiapoptotic protein bcl-xL from NMR and parallel synthesis","volume":"49","author":"Petros","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113539_bib29","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1158\/1078-0432.CCR-06-1574","article-title":"Preclinical studies of TW-37, a new nonpeptidic small-molecule inhibitor of Bcl-2, in diffuse large cell lymphoma xenograft model reveal drug action on both Bcl-2 and Mcl-1","volume":"13","author":"Mohammad","year":"2007","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.ejmech.2021.113539_bib30","first-page":"1873","article-title":"Myeloid cell leukemin-1 inhibitors: a growing arsenal for cancer therapy, Drug Discov","volume":"25","author":"Zhu","year":"2020","journal-title":"Today Off."},{"key":"10.1016\/j.ejmech.2021.113539_bib31","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.ccell.2018.11.004","article-title":"BH3-Mimetic drugs: blazing the trail for new cancer Medicines","volume":"34","author":"Merino","year":"2018","journal-title":"Canc. Cell"},{"key":"10.1016\/j.ejmech.2021.113539_bib32","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.3109\/10428194.2015.1048441","article-title":"Obatoclax in combination with fludarabine and rituximab is well-tolerated and shows promising clinical activity in relapsed chronic lymphocytic leukemia","volume":"56","author":"Brown","year":"2015","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.ejmech.2021.113539_bib33","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nature03579","article-title":"An inhibitor of Bcl-2 family proteins induces regression of solid tumours","volume":"435","author":"Oltersdorf","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2021.113539_bib34","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1038\/sj.cdd.4401937","article-title":"Comparison of chemical inhibitors of antiapoptotic Bcl-2-family proteins","volume":"13","author":"Zhai","year":"2006","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ejmech.2021.113539_bib35","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1091\/mbc.2.5.403","article-title":"Novel expression pattern of a new member of the MIP-1 family of cytokine-like genes","volume":"2","author":"Orlofsky","year":"1991","journal-title":"Cell Regul."},{"key":"10.1016\/j.ejmech.2021.113539_bib36","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.biocel.2014.11.015","article-title":"Role of the pro-survival molecule Bfl-1 in melanoma","volume":"59","author":"Hind","year":"2015","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.ejmech.2021.113539_bib37","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.biocel.2010.12.014","article-title":"Bfl-1\/A1 acts as a negative regulator of autophagy in mycobacteria infected macrophages","volume":"43","author":"Kathania","year":"2011","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.ejmech.2021.113539_bib38","doi-asserted-by":"crossref","first-page":"3590","DOI":"10.1016\/j.febslet.2008.09.028","article-title":"Completing the family portrait of the anti-apoptotic Bcl-2 proteins: crystal structure of human Bfl-1 in complex with Bim","volume":"582","author":"Herman","year":"2008","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejmech.2021.113539_bib39","doi-asserted-by":"crossref","first-page":"30257","DOI":"10.1074\/jbc.M109.040824","article-title":"C-terminal residues regulate localization and function of the antiapoptotic protein Bfl-1","volume":"284","author":"Brien","year":"2009","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2021.113539_bib40","doi-asserted-by":"crossref","first-page":"22781","DOI":"10.1074\/jbc.M201469200","article-title":"Bcl-2 family member Bfl-1\/A1 sequesters truncated bid to inhibit is collaboration with pro-apoptotic Bak or Bax","volume":"277","author":"Werner","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2021.113539_bib41","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1038\/sj.onc.1210771","article-title":"Bfl-1\/A1 functions, similar to Mcl-1, as a selective tBid and Bak antagonist","volume":"27","author":"Simmons","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.ejmech.2021.113539_bib42","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/07391102.2012.691363","article-title":"Relationship between helix stability and binding affinities: molecular dynamics simulations of Bfl-1\/A1-binding pro-apoptotic BH3 peptide helices in explicit solvent","volume":"31","author":"Modi","year":"2013","journal-title":"J.\u00a0Biomol. Struct. Dyn."},{"key":"10.1016\/j.ejmech.2021.113539_bib43","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ccr.2006.03.027","article-title":"Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members","volume":"9","author":"Certo","year":"2006","journal-title":"Canc. Cell"},{"key":"10.1016\/j.ejmech.2021.113539_bib44","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1021\/acschembio.6b00962","article-title":"hBfl-1\/hNOXA interaction studies provide new insights on the role of bfl-1 in cancer cell resistance and for the design of novel anticancer agents","volume":"12","author":"Barile","year":"2017","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2021.113539_bib45","first-page":"1275","article-title":"Mouse ING1 homologue, a protein interacting with A1, enhances cell death and is inhibited by A1 in mammary epithelial cells","volume":"62","author":"Seckho Ha","year":"2002","journal-title":"Canc. Res."},{"key":"10.1016\/j.ejmech.2021.113539_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0038620","article-title":"\u03bc-Calpain conversion of antiapoptotic Bfl-1 (BCL2A1) into a prodeath factor reveals two distinct alpha-helices inducing mitochondria-mediated apoptosis","volume":"7","author":"Valero","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.ejmech.2021.113539_bib47","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/jcb.20381","article-title":"C-terminal region of Bfl-1 induces cell death that accompanies caspase activation when fused with GFP","volume":"94","author":"Yang","year":"2005","journal-title":"J.\u00a0Cell. Biochem."},{"key":"10.1016\/j.ejmech.2021.113539_bib48","article-title":"The C-terminal region of Bfl-1 sensitizes nonsmall cell lung cancer to gemcitabine-induced apoptosis by suppressing NF-\u03baB activity and down-regulating Bfl-1","volume":"10","author":"Kim","year":"2011","journal-title":"Mol. Canc."},{"key":"10.1016\/j.ejmech.2021.113539_bib49","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/cdd.2015.130","article-title":"Conditional knockdown of BCL2A1 reveals rate-limiting roles in BCR-dependent B-cell survival","volume":"23","author":"Sochalska","year":"2015","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ejmech.2021.113539_bib50","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1038\/onc.2016.362","article-title":"MYC selects against reduced BCL2A1\/A1 protein expression during B cell lymphomagenesis","volume":"36","author":"Sochalska","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.ejmech.2021.113539_bib51","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1755-8794-1-13","article-title":"The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis","volume":"1","author":"Riker","year":"2008","journal-title":"BMC Med. Genom."},{"key":"10.1016\/j.ejmech.2021.113539_bib52","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1038\/sj.cdd.4401814","article-title":"Overexpression of the antiapoptotic protein A1 promotes the survival of double positive thymocytes awaiting positive selection","volume":"13","author":"Verschelde","year":"2005","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ejmech.2021.113539_bib53","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1182\/blood.V99.9.3350","article-title":"Perturbation of B-cell development in mice overexpressing the Bcl-2 homolog A1","volume":"99","author":"Chuang","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.ejmech.2021.113539_bib54","doi-asserted-by":"crossref","first-page":"5828","DOI":"10.1038\/sj.onc.1210363","article-title":"Downregulation of Bfl-1 protein expression sensitizes malignant B cells to apoptosis","volume":"26","author":"Brien","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.ejmech.2021.113539_bib55","doi-asserted-by":"crossref","first-page":"6032","DOI":"10.1182\/blood-2011-12-399089","article-title":"Targeting antiapoptotic A1\/Bfl-1 by in\u00a0vivo RNAi reveals multiple roles in leukocyte development in mice","volume":"119","author":"Ottina","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.ejmech.2021.113539_bib56","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1172\/JCI29401","article-title":"Functional validation of the anaplastic lymphoma kinase signature identifies CEBPB and BCL2A1 as critical target genes","volume":"116","author":"Piva","year":"2006","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ejmech.2021.113539_bib57","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1038\/onc.2008.466","article-title":"MYC-induced myeloid leukemogenesis is accelerated by all six members of the antiapoptotic BCL family","volume":"28","author":"Beverly","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.ejmech.2021.113539_bib58","article-title":"Selective induction of cell death in melanoma cell lines through targeting of mcl-1 and A1","volume":"7","author":"Daniela Senft","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.ejmech.2021.113539_bib59","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1177\/0961203306075382","article-title":"Overexpression of the antiapoptotic gene Bfl-1 in B cells from patients with familial systemic lupus erythematosus","volume":"16","author":"Andre","year":"2007","journal-title":"Lupus"},{"key":"10.1016\/j.ejmech.2021.113539_bib60","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1182\/blood-2004-07-2947","article-title":"Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response","volume":"105","author":"Monti","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.ejmech.2021.113539_bib61","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.cancergen.2017.03.009","article-title":"The novel double-hit, t(8;22)(q24;q11)\/MYC-IGL and t(14;15)(q32;q24)\/IGH-BCL2A1, in diffuse large B-cell lymphoma","volume":"214-215","author":"Akasaka","year":"2017","journal-title":"Canc. Genet."},{"key":"10.1016\/j.ejmech.2021.113539_bib62","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1023\/A:1018773123899","article-title":"Bcl-2 gene family and related proteins in mammary gland involution and breast cancer","volume":"4","author":"Kristel Schorr","year":"1999","journal-title":"J.\u00a0Mammary Gland Biol. Neoplasia"},{"key":"10.1016\/j.ejmech.2021.113539_bib63","first-page":"225","article-title":"Bfl-1 gene expression in breast cancer: its relationship with other prognostic factors","volume":"18","author":"Y","year":"2003","journal-title":"J.\u00a0Kor. Med. Sci."},{"key":"10.1016\/j.ejmech.2021.113539_bib64","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41392-018-0013-x","article-title":"Targeting MUC1-C suppresses BCL2A1 in triple-negative breast cancer","volume":"3","author":"Hiraki","year":"2018","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.ejmech.2021.113539_bib65","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3748\/wjg.15.356","article-title":"Genomic-wide analysis of lymphatic metastasis-associated genes in human hepatocellular carcinoma","volume":"15","author":"Lee","year":"2009","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejmech.2021.113539_bib66","first-page":"337","article-title":"Apoptosis in liver diseases-detection and therapeutic applications","volume":"11","author":"Saeid Ghavami","year":"2005","journal-title":"Med. Sci. Mon. Int. Med. J. Exp. Clin. Res."},{"key":"10.1016\/j.ejmech.2021.113539_bib67","doi-asserted-by":"crossref","first-page":"4321","DOI":"10.1073\/pnas.1205575110","article-title":"BCL2A1 is a lineage-specific antiapoptotic melanoma oncogene that confers resistance to BRAF inhibition","volume":"110","author":"Haq","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2021.113539_bib68","doi-asserted-by":"crossref","first-page":"4909","DOI":"10.1158\/0008-5472.CAN-12-2194","article-title":"Roles for endothelin receptor B and BCL2A1 in spontaneous CNS metastasis of melanoma","volume":"72","author":"Cruz-Munoz","year":"2012","journal-title":"Canc. Res"},{"key":"10.1016\/j.ejmech.2021.113539_bib69","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/cdd.2017.25","article-title":"The Bcl2a1 gene cluster finally knocked out: first clues to understanding the enigmatic role of the Bcl-2 protein A1","volume":"24","author":"Berberich","year":"2017","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ejmech.2021.113539_bib70","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1038\/sj.onc.1208282","article-title":"Oxidative stress attenuates Fas-mediated apoptosis in Jurkat T cell line through Bfl-1 induction","volume":"24","author":"Kim","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.ejmech.2021.113539_bib71","doi-asserted-by":"crossref","first-page":"5923","DOI":"10.1128\/MCB.19.9.5923","article-title":"NF-kB induces expression of the bcl-2 homologue A1\/bfl-1 to preferentially suppress chemotherapy-induced apoptosis","volume":"19","author":"Wang","year":"1999","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2021.113539_bib72","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/sj.cdd.4401830","article-title":"Reactive oxygen species mediate crosstalk between NF-kB and JNK","volume":"13","author":"Nakano","year":"2006","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ejmech.2021.113539_bib73","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/leu.2010.26","article-title":"The anti-apoptotic gene BCL2A1 is a novel transcriptional target of PU.1","volume":"24","author":"Jenal","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.ejmech.2021.113539_bib74","doi-asserted-by":"crossref","first-page":"7916","DOI":"10.4049\/jimmunol.175.12.7916","article-title":"Retinoid x receptor agonists increase bcl2a1 expression and decrease apoptosis of naive T lymphocytes","volume":"175","author":"Rasooly","year":"2005","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ejmech.2021.113539_bib75","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/sj.leu.2404198","article-title":"Upregulation of Bfl-1\/A1 in leukemia cells undergoing differentiation by all-trans retinoic acid treatment attenuates chemotherapeutic agent-induced apoptosis","volume":"20","author":"Xia","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.ejmech.2021.113539_bib76","doi-asserted-by":"crossref","first-page":"5561","DOI":"10.4049\/jimmunol.1103415","article-title":"Suppressors of cytokine signaling promote Fas-induced apoptosis through downregulation of NF-\u03baB and mitochondrial Bfl-1 in leukemic T cells","volume":"189","author":"Oh","year":"2012","journal-title":"J.\u00a0Immunol."},{"issue":"4","key":"10.1016\/j.ejmech.2021.113539_bib77","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.bbrc.2019.04.080","article-title":"Prenylated Rab acceptor RABAC1 inhibits anti-apoptotic protein BCL2A1 and induces apoptosis","volume":"513","author":"Kim","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2021.113539_bib78","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1080\/15384101.2019.1653107","article-title":"MiR-140-5p inhibits cell proliferation and metastasis by regulating MUC1 via BCL2A1\/MAPK pathway in triple negative breast cancer","volume":"18","author":"Yu","year":"2019","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ejmech.2021.113539_bib79","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.1182\/blood-2009-08-236760","article-title":"Defective ubiquitin-mediated degradation of antiapoptotic Bfl-1 predisposes to lymphoma","volume":"115","author":"Fan","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.ejmech.2021.113539_bib80","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/sj.cdd.4401684","article-title":"Constitutiveproteasome-mediatedturnoverofBfl-1\/A1 and its processing in response to TNF receptor activation in FL5.12 pro-B cells convert it into a prodeath factor","volume":"12","author":"Jf Kucharczak","year":"2005","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ejmech.2021.113539_bib81","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/ijc.20614","article-title":"High expression of bfl-1 contributes to the apoptosis resistant phenotype in B-cell chronic lymphocytic leukemia","volume":"113","author":"Morales","year":"2005","journal-title":"Int. J. Canc."},{"key":"10.1016\/j.ejmech.2021.113539_bib82","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/sj.bjc.6603951","article-title":"Upregulation of bfl-1 is a potential mechanism of chemoresistance in B-cell chronic lymphocytic leukaemia","volume":"97","author":"Olsson","year":"2007","journal-title":"Br. J. Canc."},{"key":"10.1016\/j.ejmech.2021.113539_bib83","doi-asserted-by":"crossref","first-page":"3304","DOI":"10.1182\/blood-2009-07-233304","article-title":"Acquired resistance to ABT-737 in lymphoma cells that up-regulate MCL-1 and BFL-1","volume":"115","author":"Yecies","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.ejmech.2021.113539_bib84","first-page":"3","article-title":"BFL-1 expression determines the efficacy of venetoclax in MYC+\/BCL2+ double hit lymphoma","volume":"5","author":"Roue","year":"2018","journal-title":"Oncoscience"},{"key":"10.1016\/j.ejmech.2021.113539_bib85","doi-asserted-by":"crossref","first-page":"4695","DOI":"10.1182\/blood-2005-10-4025","article-title":"The antiapoptotic gene A1\/BFL1 is a WT1 target gene that mediates granulocytic differentiation and resistance to chemotherapy","volume":"107","author":"Simpson","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.ejmech.2021.113539_bib86","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1038\/s41388-017-0111-1","article-title":"The BET bromodomain inhibitor CPI203 overcomes resistance to ABT-199 (venetoclax) by downregulation of BFL-1\/A1 in in\u00a0vitro and in\u00a0vivo models of MYC+\/BCL2+ double hit lymphoma","volume":"37","author":"Esteve-Arenys","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.ejmech.2021.113539_bib87","doi-asserted-by":"crossref","first-page":"27201","DOI":"10.1074\/jbc.271.44.27201","article-title":"Endothelial cell death induced by tumor necrosis factor-a is inhibited by the bcl-2 family member, A1,","volume":"271","author":"Aly Karsan","year":"1996","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2021.113539_bib88","first-page":"1376","article-title":"Monocytes stimulate expression of the bcl-2 family member, A1, in endothelial cells and confer protection against apoptosis","volume":"162","author":"Karen","year":"1999","journal-title":"Am. Assoc. Immunol."},{"key":"10.1016\/j.ejmech.2021.113539_bib89","doi-asserted-by":"crossref","first-page":"701305","DOI":"10.1155\/2013\/701305","article-title":"Targeting BCL2 family in human myeloid dendritic cells: a challenge to cure diseases with chronic inflammations associated with bone loss","volume":"2013","author":"Olsson Akefeldt","year":"2013","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.ejmech.2021.113539_bib90","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.23","article-title":"The anti-apoptotic Bcl-2 family protein A1\/Bfl-1 regulates neutrophil survival and homeostasis and is controlled via PI3K and JAK\/STAT signaling","volume":"7","author":"Vier","year":"2016","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2021.113539_bib91","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1111\/j.1398-9995.2006.01024.x","article-title":"IgE-receptor activation induces survival and Bfl-1 expression in human mast cells but not basophils","volume":"61","author":"Xiang","year":"2006","journal-title":"Allergy"},{"key":"10.1016\/j.ejmech.2021.113539_bib92","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.4049\/jimmunol.1400637","article-title":"Knockdown of the antiapoptotic Bcl-2 family member A1\/Bfl-1 protects mice from anaphylaxis","volume":"194","author":"Ottina","year":"2015","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ejmech.2021.113539_bib93","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1084\/jem.194.11.1561","article-title":"Essential role of the prosurvival bcl-2 homologue A1 in mast cell survival after allergic activation","volume":"194","author":"Xiang","year":"2001","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ejmech.2021.113539_bib94","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039117","article-title":"Anti-apoptotic BFL-1 is the major effector in activation-induced human mast cell survival","volume":"7","author":"Ekoff","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.ejmech.2021.113539_bib95","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/s10875-007-9153-4","article-title":"Fc gamma RI-mediated activation of human mast cells promotes survival and induction of the pro-survival gene Bfl-1","volume":"28","author":"Karlberg","year":"2008","journal-title":"J.\u00a0Clin. Immunol."},{"key":"10.1016\/j.ejmech.2021.113539_bib96","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.nbd.2011.05.013","article-title":"Bcl2-A1 interacts with pro-caspase-3: implications for amyotrophic lateral sclerosis","volume":"43","author":"Iaccarino","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ejmech.2021.113539_bib97","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1038\/sj.cdd.4401943","article-title":"Bcl2a1 serves as a switch in death of motor neurons in amyotrophic lateral sclerosis","volume":"13","author":"Crosio","year":"2006","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ejmech.2021.113539_bib98","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s003359900567","article-title":"Bfl-1, a Bcl-2-related gene, is the human homolog of the murine A1, and maps to Chromosome 15q24.3","volume":"8","author":"Choi","year":"1997","journal-title":"Mamm. Genome"},{"key":"10.1016\/j.ejmech.2021.113539_bib99","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/j.bbamcr.2013.03.001","article-title":"The C-terminal domain of A1\/Bfl-1 regulates its anti-inflammatory function in human endothelial cells","volume":"1833","author":"Guedes","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejmech.2021.113539_bib100","doi-asserted-by":"crossref","first-page":"13663","DOI":"10.1074\/jbc.M600266200","article-title":"The stability and anti-apoptotic function of A1 are controlled by its C terminus","volume":"281","author":"Herold","year":"2006","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2021.113539_bib101","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1038\/sj.onc.1206274","article-title":"Bfl-1S, a novel alternative splice variant of Bfl-1, localizes in the nucleus via its C-terminus and prevents cell death","volume":"22","author":"Ko","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.ejmech.2021.113539_bib102","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s003359900418","article-title":"The bcl-2 family member, Bcl2al, maps to mouse Chromosome 9 and human Chromosome 15","volume":"8","author":"Elaine","year":"1997","journal-title":"Mamm. Genome"},{"key":"10.1016\/j.ejmech.2021.113539_bib103","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/intimm\/10.5.631","article-title":"Fujiro sendo, keiko nakayama and kei-ichi nakayama, multiple-gene-duplication-and-expression-of-mouse-bcl-2-related-genes-A1","volume":"10","author":"Shigetsugu Hatakeyama","year":"1998","journal-title":"Int. Immunol."},{"key":"10.1016\/j.ejmech.2021.113539_bib104","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.str.2017.11.016","article-title":"Crystal structures of anti-apoptotic BFL-1 and its complex with a covalent stapled peptide inhibitor","volume":"26","author":"Harvey","year":"2018","journal-title":"Structure"},{"key":"10.1016\/j.ejmech.2021.113539_bib105","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/s41594-020-0458-9","article-title":"A\u00a0redox switch regulates the structure and function of anti-apoptotic BFL-1","volume":"27","author":"Korshavn","year":"2020","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.ejmech.2021.113539_bib106","doi-asserted-by":"crossref","first-page":"6275","DOI":"10.1021\/jm4011675","article-title":"Hydrocarbon-stapled peptides: principles, practice, and progress","volume":"57","author":"Walensky","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113539_bib107","doi-asserted-by":"crossref","first-page":"10070","DOI":"10.1073\/pnas.0502402102","article-title":"Modifying specific cysteines of the electrophile-sensing human Keap1 protein is insufficient to disrupt binding to the Nrf2 domain Neh2","volume":"102","author":"Eggler","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2021.113539_bib108","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nsmb.2563","article-title":"BID-induced structural changes in BAK promote apoptosis","volume":"20","author":"Moldoveanu","year":"2013","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.ejmech.2021.113539_bib109","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1021\/cb4003305","article-title":"Distinct BimBH3 (BimSAHB) stapled peptides for structural and cellular studies","volume":"9","author":"Bird","year":"2014","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2021.113539_bib110","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nsmb.2717","article-title":"A\u00a0phospho-BAD BH3 helix activates glucokinase by a mechanism distinct from that of allosteric activators","volume":"21","author":"Szlyk","year":"2014","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.ejmech.2021.113539_bib111","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1038\/srep03451","article-title":"Rational optimization of conformational effects induced by hydrocarbon staples in peptides and their binding interfaces","volume":"3","author":"Lama","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2021.113539_bib112","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.chembiol.2016.07.022","article-title":"Selective covalent targeting of anti-apoptotic BFL-1 by cysteine-reactive stapled peptide inhibitors","volume":"23","author":"Huhn","year":"2016","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.ejmech.2021.113539_bib113","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1016\/j.celrep.2018.08.089","article-title":"Precision targeting of BFL-1\/A1 and an ATM Co-dependency in human cancer","volume":"24","author":"Guerra","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.ejmech.2021.113539_bib114","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1021\/acsmedchemlett.6b00395","article-title":"Electrophilic helical peptides that bond covalently, irreversibly, and selectively in a protein-protein interaction site","volume":"8","author":"de Araujo","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2021.113539_bib115","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1021\/acs.jmedchem.8b00010","article-title":"Bicyclic helical peptides as dual inhibitors selective for Bcl2A1 and mcl-1 proteins","volume":"61","author":"A","year":"2018","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113539_bib116","first-page":"6","article-title":"Epistatic mutations in PUMA BH3 drive an alternate binding mode to potently and selectively inhibit anti-apoptotic Bfl-1","author":"Jenson","year":"2017","journal-title":"Elife"},{"key":"10.1016\/j.ejmech.2021.113539_bib117","doi-asserted-by":"crossref","first-page":"6560","DOI":"10.1016\/j.bmcl.2010.09.046","article-title":"Inhibition of bfl-1 with N-aryl maleimides","volume":"20","author":"Cashman","year":"2010","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"3","key":"10.1016\/j.ejmech.2021.113539_bib118","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1177\/1087057111429372","article-title":"High-throughput fluorescence polarization assay for chemical library screening against anti-apoptotic bcl-2 family member bfl-1","volume":"17","author":"Dayong Zhai","year":"2012","journal-title":"J.\u00a0Biomol. Screen"},{"key":"10.1016\/j.ejmech.2021.113539_bib119","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1177\/1087057114534070","article-title":"Identification of small inhibitory molecules targeting the bfl-1 anti-apoptotic protein that alleviates resistance to ABT-737","volume":"19","author":"Mathieu","year":"2014","journal-title":"J.\u00a0Biomol. Screen"},{"key":"10.1016\/j.ejmech.2021.113539_bib120","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1021\/acs.jmedchem.9b01442","article-title":"Discovery and characterization of 2,5-substituted benzoic acid dual inhibitors of the anti-apoptotic mcl-1 and bfl-1 proteins","volume":"63","author":"Kump","year":"2020","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113539_bib121","series-title":"PCT Int. Appl.","article-title":"Inhibitors of MCL-1 and\/or BFL-1\/A1 as antitumor agents","author":"Walensky","year":"2013"},{"key":"10.1016\/j.ejmech.2021.113539_bib122","series-title":"U.S. Pat. Appl. Publ.","article-title":"Inhibition of mcl-1 and\/or bfl-1\/a1","author":"Walensky","year":"2015"},{"key":"10.1016\/j.ejmech.2021.113539_bib123","doi-asserted-by":"crossref","first-page":"13815","DOI":"10.1073\/pnas.1313098110","article-title":"A\u00a0high-throughput screen for quorum-sensing inhibitors that target acyl-homoserine lactone synthases","volume":"110","author":"Christensen","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2021.113539_bib124","series-title":"Compounds Targeting the BFL-1 Anti-apoptotic Protein and Uses Thereof for the Treatment of Cancer","author":"Leroux","year":"2016"},{"key":"10.1016\/j.ejmech.2021.113539_bib125","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.chembiol.2020.04.004","article-title":"Identification of a covalent molecular inhibitor of anti-apoptotic BFL-1 by disulfide tethering","volume":"27","author":"Harvey","year":"2020","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.ejmech.2021.113539_bib126","doi-asserted-by":"crossref","first-page":"4166","DOI":"10.1021\/jm1001265","article-title":"BI-97C1, an optically pure Apogossypol derivative as pan-active inhibitor of antiapoptotic B-cell lymphoma\/leukemia-2 (Bcl-2) family proteins","volume":"53","author":"Wei","year":"2010","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113539_bib127","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3389\/fonc.2011.00028","article-title":"An optically pure apogossypolone derivative as potent pan-active inhibitor of anti-apoptotic bcl-2 family proteins","volume":"1","author":"Wei","year":"2011","journal-title":"Front Oncol"},{"key":"10.1016\/j.ejmech.2021.113539_bib128","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1158\/1535-7163.MCT-07-2373","article-title":"Gambogic acid is an antagonist of antiapoptotic Bcl-2 family proteins","volume":"7","author":"Zhai","year":"2008","journal-title":"Mol. Canc. Therapeut."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421003883?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421003883?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:32:29Z","timestamp":1759329149000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523421003883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":128,"alternative-id":["S0223523421003883"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113539","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibitors of BCL2A1\/Bfl-1 protein: Potential stock in cancer therapy","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113539","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113539"}}